Assembly Concurrent Resolution 56 is a nonbinding legislative resolution that designates April 2025 as Parkinson’s Disease Awareness Month in California. The resolution recites background information about Parkinson’s disease, including its symptoms, prevalence, economic costs, lack of a cure, and the need for research, education, and support services. It also highlights California-specific efforts such as the California Parkinson’s Disease Registry and the expanded California Neurodegenerative Disease Registry, along with research contributions from the Michael J. Fox Foundation and California universities.
The measure does not create or amend substantive law, impose regulatory requirements, or appropriate funds. Its legal effect is limited to an official state recognition of Parkinson’s Disease Awareness Month and the transmission of copies of the resolution for distribution. Because it is a concurrent resolution, it serves primarily as a statement of legislative support and public awareness rather than a change to statutes or agency duties.
Impact
ACR 56 has no direct impact on California statutes, regulations, or state programs beyond formally recognizing April 2025 as Parkinson’s Disease Awareness Month. It does not alter the California Health and Safety Code, the state registry framework, or any health care coverage or reporting requirements. Its practical effect is symbolic and promotional, intended to raise awareness among the public, caregivers, researchers, and health care providers about Parkinson’s disease and related support and research efforts.
Sentiment
The overall sentiment around the bill appears strongly positive and noncontroversial. The resolution passed its committee and floor votes unanimously, with no recorded opposition in the available voting history. The bill’s framing emphasizes public health awareness, research progress, and support for affected Californians, which likely contributed to the broad bipartisan support.
Contention
There is no notable policy contention reflected in the available materials. The resolution is largely commemorative, and the discussion points embedded in the text focus on the seriousness of Parkinson’s disease, the burden on patients and families, and the value of research and registries. Any differences of view would likely have centered only on the symbolic nature of the measure versus more substantive policy responses, but no such disagreement appears in the votes or record provided.